Maternal tenofovir along with Vaccination may prevent Vertical Hepatitis B transmission Medical Dialogues Editorial Team29 March 2022 9:00 AM ISTIn babies, a combination of hepatitis B vaccination and immunoglobulin is the cornerstone of vertical transmission prevention for women who are...
Serum Institute seeks DCGI emergency use nod for rBCG tuberculosis vaccine Ruchika Sharma28 March 2022 12:00 PM ISTNew Delhi: The Serum Institute has applied to the Drugs Controller General of India seeking emergency use authorisation for its recombinant BCG (rBCG)...
Sapigen Biologix, Technology Development Board collaborate for malaria, COVID nasal vaccine Ruchika Sharma28 March 2022 11:00 AM ISTNew Delhi: The Technology Development Board (TDB) of the Union Ministry of Science and Technology and Sapigen Biologix Private Limited, Hyderabad on...
2 dose Hepatitis B vaccine not significantly associated with increased MI risk compared to 3 dose vaccine: JAMA Medical Dialogues Editorial Team28 March 2022 9:00 AM ISTWhen comparing the hepatitis B vaccination with a cytosine phosphoguanine adjuvant (HepB-CpG) vaccination to the HepB-alum vaccine, the statistical...
Pfizer gets USFDA Breakthrough Therapy Designation for RSV Vaccine Ruchika Sharma26 March 2022 9:45 AM ISTNew York: Pfizer Inc. has announced that its respiratory syncytial virus (RSV) vaccine candidate, PF-06928316 or RSVpreF, has received...
SII Covovax gets DCGI emergency use nod for 12 to 18 year olds Ruchika Sharma24 March 2022 12:09 PM ISTCovovax is the fourth vaccine to receive EUA from DCGI for use among adolescents 12 and older.
Infant COVID vaccine succeeded in trial: Moderna Ruchika Sharma24 March 2022 10:00 AM ISTCambridge: Moderna, Inc. has recently announced positive interim data from the Phase 2/3 KidCOVE study of the Moderna COVID-19 vaccine (mRNA-1273) in...
Immunocompromised COVID-19 patient successfully treated with vaccine: Case report Medha Baranwal23 March 2022 7:21 PM ISTUK: A recent case study, published in the Journal of Clinical Immunology, describes the case of a man in the UK who tested positive for coronavirus...
Decrease gap between two doses of Covishield to 8-16 weeks, suggests panel MD Bureau21 March 2022 1:00 PM ISTThe government had on May 13, 2021, extended the gap between the first and second doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks, based...
Wockhardt , Serum Life Sciences collaborate for manufacturing multiple vaccines MD Bureau21 March 2022 12:54 PM ISTThis collaboration between a subsidiary of Wockhardt and Serum Life Sciences UK will help create considerable number of employment opportunities...
Moderna submits amendment to USFDA for its COVID-19 vaccine booster dose MD Bureau20 March 2022 2:15 PM ISTThe U.S. FDA approved the Biologics License Application (BLA) for SPIKEVAX (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 18 years of age...
Is short-term follow-up suitable clinical approach for MRI-detected adenopathy after COVID-19 vaccination? Medha Baranwal18 March 2022 9:00 AM ISTUSA: Adenopathy after COVID-19 vaccination is a frequent event; short-term follow-up is a suitable clinical approach, except in patients with current...
